Protective effects of Rosmarinic acid against renal ischaemia/reperfusion injury in rats

Journal of the Pakistan Medical Association

Volumn 64, Issue 3, 2014, Pages 260-265

  Ozturk, Hulya ^a   Ozturk, Hayrettin ^a   Hakan Terzi, Elcin ^a   Ozgen, Ufuk ^b   Duran, Arif ^c   Uygun, Ibrahim ^d  

^a Department of Pediatric Surgery ^*  (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

^c ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^d DICLE UNIVERSITY   (Turkey)

Author keywords

Ischaemia reperfusion injury; Rat; Renal kidney; Rosmarinic acid

Indexed keywords

CREATININE; MALONALDEHYDE; MYELOPEROXIDASE; ROSMARINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOWMAN CAPSULE DILATATION; CONTROLLED STUDY; GLOMERULAR NECROSIS; HISTOPATHOLOGY; KIDNEY ISCHEMIA; MALE; NONHUMAN; OXIDATIVE STRESS; PROSPECTIVE STUDY; RAT; REPERFUSION INJURY; SCORING SYSTEM; TUBULAR DILATATION; TUBULAR EPITHELIUM DEGENERATION; TUBULAR EPITHELIUM NECROSIS; UREA NITROGEN BLOOD LEVEL; UROGENITAL SYSTEM PARAMETERS;

ANIMALS; BLOOD UREA NITROGEN; CINNAMATES; CREATININE; DEPSIDES; KIDNEY DISEASES; MALE; MALONDIALDEHYDE; NEPHRECTOMY; OXIDATIVE STRESS; PEROXIDASE; PROSPECTIVE STUDIES; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 84894518834     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Rondon-Berrios H, Palevsky PM. Treatment of acute kidney injury: An update on the management of renal replacement therapy. Curr Opin Nephrol Hypertens 2007; 16: 64-70.
2. Yazihan N, Ataoglu H, Kavas GO, Akyurek N, Yener B, Aydm C. The effect of K ATP channel blockage during erythropoietin treatment in renal ischemia-reperfusion injury. J Invest Surg 2008; 21: 340-7.
3. Fan LH, He L, Cao ZQ, Xiang B, Liu L. Effect of ischemia preconditioning on renal ischemia/reperfusion injury in rats. Int Braz J Urol 2012; 38: 842-54.
4. Sedaghat Z, Kadkhodaee M, Seifi B, Salehi E, Najafi A, Dargahi L. Remote preconditioning reduces oxidative stress, downregulates cyclo-oxygenase-2 expression and attenuates ischaemia-reperfusioninduced acute kidney injury. Clin Exp Pharmacol Physiol 2013; 40: 97-103.
5. Salehipour M, Monabbati A, Salahi H, Nikeghbalian S, Bahador A, Marvasti VE, et al. Protective effect of parenteral vitamin E on ischemia-reperfusion injury of rabbit kidney. Urology 2010; 75: 858-61.
6. Makino I, H Tanaka. From a choleretic to an immunomodulator: historical review of ursodeoxycholic acid as a medicament. J Gastroenterol Hepatol 1998; 13: 659-64.
7. Psotova J, Kolar M, Sousek J, Svagera Z, Vicar J, Ulrichova J. Biological activities of Prunella vulgaris extract. Phytother Res 2003; 17: 1082-7.
8. van Kessel KP, E Kalter S, Verhoef J. Rosmarinic acid inhibits external oxidative effects of human polymorphonuclear granulocytes. Agents Actions 1986; 7: 375-6.
9. Uchiyama M, Mihara M. Determination of malonaldehyde precursor in tissues by tiobarbituric acid test. Anal Biochem 1978; 34: 271-8.
10. Sun Y, Oberley L, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
11. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-70.
12. Schierwagen C, Bylund-Fellenius AC, Lundberg C. Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J Pharmacol Meth 1990; 23: 179-86.
13. Feng L, Xiong Y, Cheng F, Zhang L, Li S, Li Y. Effect of ligustrazine on ischemia-reperfusion injury in murine kidney. Transplant Proc 2004; 36: 1949-51.
14. Chatterjee PK. Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: A comprehensive review. Naunyn Schmiedebergs Arch Pharmacol 2007; 376: 1-43.
15. Erdogan H, Fadillioglu E, Yagmurca M, Ucar M, Irmak MK. Protein oxidation and lipid peroxidation after renal ischemiareperfusion injury: Protective effects of erdosteine and Nacetylcysteine. Urol Res 2006; 34: 41-6.
16. Li C, Jackson RM. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol. 2002; 282: C227-C41.
17. Peake PW, Pussell BA, Martyn P, Timmermans V, Charlesworth JA. The inhibitory effect of rosmarinic acid on complement involves the C5 convertase. Int J Immunopharmacol 1991; 13: 853-7.
18. Qiao S, Li W, Tsubouchi R, Haneda M, Murakami K, Takeuchi F, et al. Rosmarinic acid inhibits the formation of reactive oxygen and nitrogen species in RAW264.7 macrophages. Free Radical Res 2005; 39: 995-1003.
19. Petersen M, Abdullah Y, Benner J, Eberle D, Gehlen K, Hücherig S, et al. Evolution of rosmarinic acid biosynthesis. Phytochemistry 2009; 70: 1663-79.
20. Won J, Hur YG, Hur EM, Park SH, Kang MA, Choi Y, et al. Rosmarinic acid inhibits TCR-induced T cell activation and proliferation in an Lck-dependent manner. Eur J Immunol 2003; 33: 870-9.
21. Pérez-Fons L, Garzón MT, Micol V. Relationship between the antioxidant capacity and effect of rosemary (Rosmarinus officinalis L.) polyphenols on membrane phospholipid order. J Agric Food Chem 2010; 58: 161-71
22. Makino T, Ono T, Muso E, Yoshida H, Honda G, Sasayama S. Inhibitory effects of rosmarinic acid on the proliferation of cultured murine mesangial cells. Nephrol Dial Transplant 2000; 15: 1140-5.